Related Experiment Video
Updated: Jan 18, 2026

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Inhibition of the assembly of Plasmodium Hsp70-1 and Hsp40 complex blocks DNA replication by destabilizing
Iman Alkhatib1, Deepanshu Garg1, Wahida Tabassum2
1Department of Biotechnology and Bioinformatics, School of Life Sciences, University of Hyderabad, Hyderabad, Telangana, India.
Abstract:
Plasmodium falciparum undergoes endoreduplication, in which its nuclear, mitochondrial, and apicoplast genomes are replicated multiple times without cytokinesis,; enabling replication as a promising target for arresting parasite growth and pathogenicity. Previously, it was reported that the inhibition of expression of small subunit of ribonucleotide reductase (PfR2) leads to the inhibition of DNA synthesis and growth of the parasites. Here, we report the molecular determinant that is necessary for aiding early folding intermediates of PfR2. We find that PfR2 interacts with the cytosolic Type-I Hsp40-cochaperone PfYdj1 (Pf3D7_1437900), which subsequently interacts with PfHsp70-1 through its Histidine-Proline-Aspartate (HPD) motif. Such association of PfR2 is specific toward PfYdj1 and not with other cytosolic Type II Hsp40-cochaperone PfSis1 (PF3D7_0213100). We show that perturbation of association between PfYdj1 and PfHsp70-1 by small molecule 116-9e results in the disruption of PfR2 homeostasis within the parasite. As a result, there is a significant reduction in dNTP production leading to a replication arrest. We demonstrate that the combination of 116-9e and benzo-hydroxamate, a catalytic inhibitor of PfR2, works in a synergistic fashion. Together, our work suggests that targeting PfYdj1-PfHsp70-1 complex assembly in the context of ribonucleotide reductase function can be used as an attractive strategy to curb malaria.IMPORTANCERibonucleotide reductase is an important enzyme which catalyzes the reduction of ribonucleotides to deoxyribonucleotides, and inhibition of the synthesis of its catalytic subunit (PfR2) leads to significant growth inhibition in malaria parasites. Our study deciphers the molecular determinants that are essential for the maturation of PfR2. We show that Plasmodium Hsp40 cochaperone, PfYdj1 (Pf3D7_1437900), is the molecular cochaperone that facilitates the binding of PfR2 with PfHsp70-1, which is crucial for PfR2 folding and stability. We show that perturbation of the assembly between PfYdj1-PfHsp70-1 by a small molecule 116-9e destabilizes PfR2 and subsequently inhibits dNTP formation, resulting in replication arrest in the parasite. We demonstrate that 116-9e and the catalytic inhibitor of PfR2, benzo hydroxamate, potentiate each other's action. Also, the combination of both the inhibitors displays profound synergism in 3D7 parasites. We propose that the combination of 116-9e and benzo hydroxamate can be employed as an attractive anti-malaria strategy.
Insights
Targeting PfYdj1-PfHsp70-1 complex assembly disrupts malaria parasite PfR2 homeostasis, inhibiting DNA synthesis and causing replication arrest. Combining small molecule 116-9e with PfR2 inhibitor benzo-hydroxamate shows synergistic anti-malarial effects.
Area of Science:
- Malariology
- Molecular Parasitology
- Drug Discovery
Background:
- *Plasmodium falciparum* replicates via endoreduplication, making its genome replication machinery a target for anti-malarial therapies.
- Inhibition of the small subunit of ribonucleotide reductase (PfR2) arrests parasite growth by blocking DNA synthesis.
Purpose of the Study:
- To identify molecular determinants essential for PfR2 folding and maturation.
- To investigate the role of chaperones in PfR2 homeostasis.
- To evaluate novel therapeutic strategies targeting PfR2 maturation.
Main Methods:
- *In silico* and biochemical assays to identify PfR2 interacting partners.
- Small molecule screening to disrupt chaperone-chaperone interactions.
- Assessment of parasite growth inhibition and DNA synthesis in response to inhibitors.
Main Results:
- PfR2 specifically interacts with cytosolic Type-I Hsp40 cochaperone PfYdj1, which facilitates binding to PfHsp70-1.
- Small molecule 116-9e disrupts the PfYdj1-PfHsp70-1 complex, destabilizing PfR2 and reducing dNTP production.
- Combination therapy of 116-9e and benzo-hydroxamate exhibits synergistic anti-malarial activity.
Conclusions:
- PfYdj1-PfHsp70-1 complex assembly is critical for PfR2 folding and parasite survival.
- Targeting this chaperone complex offers a novel strategy for malaria treatment.
- Combined inhibition of PfR2 maturation and catalysis presents a potent synergistic anti-malarial approach.
More Related Videos
Related Concept Videos
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
The Replisome
The synthesis of the leading and lagging strands is a highly coordinated process. To explain this, the “Trombone model” was proposed by Bruce Alberts in 1980. The DNA loop formation starts when a primer is synthesized on the parent lagging strand. The loop grows with...
Negative Regulator Molecules

